1 Boehncke W-H. Graft persistence in animal models of psoriasis. Nat Med 1997; 3: 702–3.
10.1038/nm0797-702c
CAS PubMed Web of Science® Google Scholar
2 Yunis EJ, Romero V, Diaz-Giffero F et al. Natural killer cell receptor NKG2A/HLA-E interaction dependent differential thymopoiesis of hematopoietic progenitor cells influences the outcome of HIV infection. J Stem Cells 2007; 2: 237–48.
PubMed Google Scholar
3 Boehncke W-H. The psoriasis SCID mouse model: a tool for drug discovery? Ernst Schering Res Found Workshop 2005; 50: 213–34.
10.1007/3-540-26811-1_12
PubMed Web of Science® Google Scholar
4 Petersen TK, Sorensen P. Translational dermatology in drug discovery: perspectives for integrating humanized xenograft models and experimental clinical studies. Drug Discovery Today 2008; 13: 240–6.
10.1016/j.drudis.2007.10.009
PubMed Web of Science® Google Scholar
5 Chiricozzi A, Guttman-Yassky E, Suarez-Farinas M et al. Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenetic circuits in psoriasis. J Invest Dermatol 2011; 131: 677–87.
10.1038/jid.2010.340
CAS PubMed Web of Science® Google Scholar
6 Norsgaard H, Svensson L, Hagedorn PH et al. Translating clinical activity and gene expression signatures of etanercept and ciclosporin to the psoriasis xenograft SCID mouse model. Br J Dermatol 2012; 166: 649–52.
10.1111/j.1365-2133.2011.10713.x
CAS PubMed Web of Science® Google Scholar

Citing Literature

March 2012

Page 473

The psoriasis xenograft SCID mouse model: a tool in translational research